Institute of Molecular and Cell Biology (IMCB)’s Post

🧬 How do new integrase variants transform genome editing? A recent study led by Senior Investigator Farid John Ghadessy and his team at IMCB has unveiled significant advancements in DNA editing. Their study introduces novel lambda integrase variants that show more than a 1000-fold improvement in specificity for non-natural target sites. These breakthroughs hold potential for advancing biomanufacturing by enabling precise genome editing in microorganisms such as Phaeodactylum tricornutum and Nannochloropsis oceanica. Notably, the integrases also successfully target unique sequences in the human genome, presenting exciting possibilities for gene therapy and genomic research. This work represents a critical step forward in precision genome engineering, with broad implications for both biotechnology and healthcare. Check out the exciting study 👉 https://lnkd.in/guNkNC6S #IMCBastar #IMCBscience #GenomeEditing #Biotechnology #PrecisionMedicine #GeneTherapy #DNAResearch #SyntheticBiology #SustainableBiotech #ResearchInnovation

Expanding the DNA editing toolbox: Novel lambda integrase variants targeting microalgal and human genome sequences

Expanding the DNA editing toolbox: Novel lambda integrase variants targeting microalgal and human genome sequences

journals.plos.org

To view or add a comment, sign in

Explore topics